Tmall pharmaceutical stores can not sell drugs third platform for sale or will be suspended

interface

increasingly ignite the enthusiasm of the capital market, China’s pharmaceutical retail market electricity supplier, was suddenly a surprise policy changes poured cold water.

recently, Tmall Tmall settled to numerous pharmaceutical Museum merchants sent a "notification" about the emergency control measures of drug category, announced immediately suspend drug business. Tmall said in a statement said, will be notified in accordance with the Hebei food and drug administration, and actively cooperate with the third party platform to stop drug online retail business, other operations to maintain normal operations.

in addition to the pharmaceutical business (both OTC drugs), Tmall Medical Museum and medical equipment, health care products, adult supplies and other services. Data show that Tmall pharmaceutical sales last year, 1 billion yuan, OTC pharmaceutical sales of $280 million, accounting for more than 26.6%.

interface news reporter found that, as of now, consumers can still buy medicine at the Tmall medical museum. A Tmall official explained that this is because Tmall in order to ensure the interests of consumers and businesses, businesses will stop the drug trade to set up a buffer period, the exact timetable depending on the specific circumstances".

is not only a halt to the Tmall pharmaceutical museum. An insider told reporters in addition to the current interface, Hebei food and drug administration, Shanghai food and drug administration, Guangzhou food and drug administration also received the relevant notification, but not yet formally notify the relevant enterprises, shop No. 1 and eight hundred.

this means that the Internet third party platform drug online retail pilot or will be a full stop, because the current domestic only these three pilot.

previously, the State Food and Drug Administration (hereinafter referred to as CFDA) respectively in November 12, 2013, July 7, 2014, July 25, 2014 approved the eye Hebei Medical Technology Co., Ltd. 95095 pharmaceutical platform (2014 acquisition of Alibaba), Guangzhou eight hundred Information Technology Co. Ltd., Niuhai Electronic Commerce (Shanghai) Co., Ltd. (1 stores) as the Internet third party drugs online retail platform pilot". After that, no business to get the pilot qualifications.

this is being halted pilot is also known as A card pilot".

engaged in Internet drug trading companies in China, the need to obtain the CFDA issued by the Internet drug trading service agency qualification certificate, divided into A card, B card, C card three. Have A certificate enterprises can only be between drug manufacturers, drug distributors and medical institutions shall not provide the platform for service providers, drug sales services to individuals with B certificate; companies can trade with other pharmaceutical enterprises; with C card company can provide independent non prescription drugs to consumers.

therefore, the enterprise wants to carry out medical B2C business platform, there are three ways: one is displayed on the platform, when buying to jump to the C card online pharmacies to buy; two is the acquisition of the third party platform with online drug retail pilot >

interface

increasingly ignite the enthusiasm of the capital market, China’s pharmaceutical retail market electricity supplier, was suddenly a surprise policy changes poured cold water.

recently, Tmall Tmall settled to numerous pharmaceutical Museum merchants sent a "notification" about the emergency control measures of drug category, announced immediately suspend drug business. Tmall said in a statement said, will be notified in accordance with the Hebei food and drug administration, and actively cooperate with the third party platform to stop drug online retail business, other operations to maintain normal operations.

in addition to the pharmaceutical business (both OTC drugs), Tmall Medical Museum and medical equipment, health care products, adult supplies and other services. Data show that Tmall pharmaceutical sales last year, 1 billion yuan, OTC pharmaceutical sales of $280 million, accounting for more than 26.6%.

interface news reporter found that, as of now, consumers can still buy medicine at the Tmall medical museum. A Tmall official explained that this is because Tmall in order to ensure the interests of consumers and businesses, businesses will stop the drug trade to set up a buffer period, the exact timetable depending on the specific circumstances".

is not only a halt to the Tmall pharmaceutical museum. An insider told reporters in addition to the current interface, Hebei food and drug administration, Shanghai food and drug administration, Guangzhou food and drug administration also received the relevant notification, but not yet formally notify the relevant enterprises, shop No. 1 and eight hundred.

this means that the Internet third party platform drug online retail pilot or will be a full stop, because the current domestic only these three pilot.

previously, the State Food and Drug Administration (hereinafter referred to as CFDA) respectively in November 12, 2013, July 7, 2014, July 25, 2014 approved the eye Hebei Medical Technology Co., Ltd. 95095 pharmaceutical platform (2014 acquisition of Alibaba), Guangzhou eight hundred Information Technology Co. Ltd., Niuhai Electronic Commerce (Shanghai) Co., Ltd. (1 stores) as the Internet third party drugs online retail platform pilot". After that, no business to get the pilot qualifications.

this is being halted pilot is also known as A card pilot".

engaged in Internet drug trading companies in China, the need to obtain the CFDA issued by the Internet drug trading service agency qualification certificate, divided into A card, B card, C card three. Have A certificate enterprises can only be between drug manufacturers, drug distributors and medical institutions shall not provide the platform for service providers, drug sales services to individuals with B certificate; companies can trade with other pharmaceutical enterprises; with C card company can provide independent non prescription drugs to consumers.

therefore, the enterprise wants to carry out medical B2C business platform, there are three ways: one is displayed on the platform, when buying to jump to the C card online pharmacies to buy; two is the acquisition of the third party platform with online drug retail pilot >

Leave a Reply

Your email address will not be published. Required fields are marked *